Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

1.

Discrepant Glucose Results between Capillary and Venous Blood in an 83-Year-Old White Man.

Mika LM, Guyette MK, Pillage G, Tamama K.

Lab Med. 2014 Fall;45(4):e156-7. doi: 10.1309/LMT5E3T4VRUNFLCS.

PMID:
25425027
2.

Ranitidine interference with standard amphetamine immunoassay.

Liu L, Wheeler SE, Rymer JA, Lower D, Zona J, Peck Palmer OM, Tamama K.

Clin Chim Acta. 2015 Jan 1;438:307-8. doi: 10.1016/j.cca.2014.09.012. Epub 2014 Sep 19.

PMID:
25242739
3.

Early growth response-2 signaling mediates immunomodulatory effects of human multipotential stromal cells.

Barbeau DJ, La KT, Kim DS, Kerpedjieva SS, Shurin GV, Tamama K.

Stem Cells Dev. 2014 Jan 15;23(2):155-66. doi: 10.1089/scd.2013.0194. Epub 2013 Oct 5.

4.

Metabolic acidosis with discrepant lactate results.

Berg A, Tamama K, Peck Palmer OM.

Clin Chem. 2013 Apr;59(4):713-4. doi: 10.1373/clinchem.2012.197939. No abstract available.

5.

Early growth response genes signaling supports strong paracrine capability of mesenchymal stem cells.

Tamama K, Barbeau DJ.

Stem Cells Int. 2012;2012:428403. doi: 10.1155/2012/428403. Epub 2012 Dec 6.

6.

Ketoacidosis and trace amounts of isopropanol in a chronic alcoholic patient.

Dwyer JB, Tamama K.

Clin Chim Acta. 2013 Jan 16;415:245-9. doi: 10.1016/j.cca.2012.10.057. Epub 2012 Nov 13.

PMID:
23159845
7.
8.

EGFR ligands drive multipotential stromal cells to produce multiple growth factors and cytokines via early growth response-1.

Kerpedjieva SS, Kim DS, Barbeau DJ, Tamama K.

Stem Cells Dev. 2012 Sep 1;21(13):2541-51. doi: 10.1089/scd.2011.0711. Epub 2012 Mar 8.

9.

Differential roles of hypoxia inducible factor subunits in multipotential stromal cells under hypoxic condition.

Tamama K, Kawasaki H, Kerpedjieva SS, Guan J, Ganju RK, Sen CK.

J Cell Biochem. 2011 Mar;112(3):804-17. doi: 10.1002/jcb.22961.

10.

Hydrogen gas treatment prolongs replicative lifespan of bone marrow multipotential stromal cells in vitro while preserving differentiation and paracrine potentials.

Kawasaki H, Guan J, Tamama K.

Biochem Biophys Res Commun. 2010 Jul 2;397(3):608-13. doi: 10.1016/j.bbrc.2010.06.009. Epub 2010 Jun 4.

PMID:
20570654
11.

Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC.

Tamama K, Kawasaki H, Wells A.

J Biomed Biotechnol. 2010;2010:795385. doi: 10.1155/2010/795385. Epub 2010 Feb 17. Review.

12.

Injectable, rapid gelling and highly flexible hydrogel composites as growth factor and cell carriers.

Wang F, Li Z, Khan M, Tamama K, Kuppusamy P, Wagner WR, Sen CK, Guan J.

Acta Biomater. 2010 Jun;6(6):1978-91. doi: 10.1016/j.actbio.2009.12.011. Epub 2009 Dec 23.

PMID:
20004745
13.

Fabrication and characterization of prosurvival growth factor releasing, anisotropic scaffolds for enhanced mesenchymal stem cell survival/growth and orientation.

Wang F, Li Z, Tamama K, Sen CK, Guan J.

Biomacromolecules. 2009 Sep 14;10(9):2609-18. doi: 10.1021/bm900541u.

PMID:
19689108
14.

Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway.

Tamama K, Sen CK, Wells A.

Stem Cells Dev. 2008 Oct;17(5):897-908. doi: 10.1089/scd.2007.0155.

15.

Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells.

Fan VH, Tamama K, Au A, Littrell R, Richardson LB, Wright JW, Wells A, Griffith LG.

Stem Cells. 2007 May;25(5):1241-51. Epub 2007 Jan 18.

16.

Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells.

Tamama K, Fan VH, Griffith LG, Blair HC, Wells A.

Stem Cells. 2006 Mar;24(3):686-95. Epub 2005 Sep 8.

17.

High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component.

Tamama K, Tomura H, Sato K, Malchinkhuu E, Damirin A, Kimura T, Kuwabara A, Murakami M, Okajima F.

Atherosclerosis. 2005 Jan;178(1):19-23.

PMID:
15585196
18.

Hormone replacement therapy causes a decrease in hepatocyte growth factor in hypertensive women.

Tamama K, Sumino H, Ichikawa S, Kanda T, Kotajima N, Fukumura Y, Kurabayashi M, Murakami M.

J Hypertens. 2003 Jun;21(6):1151-6.

PMID:
12777952
19.

High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors.

Kimura T, Sato K, Malchinkhuu E, Tomura H, Tamama K, Kuwabara A, Murakami M, Okajima F.

Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1283-8. Epub 2003 May 29.

20.

Sphingosine 1-phosphate signaling in atherosclerosis and vascular biology.

Tamama K, Okajima F.

Curr Opin Lipidol. 2002 Oct;13(5):489-95. Review.

PMID:
12352012
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk